United States · FDA National Drug Code directory
Everolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72319-003_5afb5d8b-631c-48bd-e063-6294a90acfe3
- Product NDC
- 72319-003
- Form
- TABLET
- Composition / generic term
- everolimus
- Labeler
- i3 Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260807
- Source listing expiry
- 20271231
Source-listed ingredients
- EVEROLIMUS — .25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 CONTAINER (72319-003-02) · 72319-003-02
- 60 BLISTER PACK in 1 CARTON (72319-003-60) / 10 TABLET in 1 BLISTER PACK (72319-003-10) · 72319-003-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →